Roche Pharma launches multiple sclerosis treatment drug in India

The company has introduced Ocrevus (Ocrelizumab) which is the first and only approved disease modifying therapy for both Relapsing Remitting Multiple Sclerosis (RRMS) and Primary Progressive Multiple Sclerosis (PPMS).

Related Keywords

India ,Roche Pharma ,Ocrevus Ocrelizumab ,V Simpson Emmanuel , ,Pharma India ,Multiple Sclerosis ,Relapsing Remitting Multiple Sclerosis ,Primary Progressive Multiple Sclerosis ,Managing Directorv Simpson Emmanuel ,Sclerosis Treatment ,